New risk; threats and opportunities

Adrian Fellows1,2,2 1Gama Healthcare Ltd 2AGA nanotech Ltd 3Gama Australia Pty. Ltd Introduction: The development of antibiotic-resistance requires new therapeutic approaches. We evaluated the antimicrobial activity of microparticles loaded with biocide precursors against MRSA and CREC. Methods: Sodium percarbonate and...
  • August 1, 2017
Read More
Ms Jo-anne Mcshane1, Dr Andrew  Maclean1,2, Mrs Leanne Houston4, Mrs Helen Marquand4, Ms Madeleine Smith1, A/Prof Mary O’Reilly2,3 1Emergency Department,  Eastern Health, Box Hill, Australia, 2Eastern Health Clinical School, Monash University Faculty of Medicine, Nursing and Health Sciences, Box Hill,...
  • July 31, 2017
Read More
Ms Alexandra Marmor1,4, Dr Kathryn Daveson1,2, Associate Professor David Harley3, Dr Karina  Kennedy1,2 1Australian National University, Acton, Australia, 2The Canberra Hospital, Garran, Australia, 3Queensland Centre for Intellectual and Developmental Disability, Mater Research Institute, University of Queensland, Raymond Terrace, Australia, 4Australian...
  • July 31, 2017
Read More
Prof. Ramon Shaban1,2,10, Dr Samuel Maloney2,3, Dr John Gerrard2,3, Professor Peter Collignon4,5,6, Dr Deborough Macbeth2,10, Professor Marilyn Cruickshank10, Dr Anna Hume2,3, Dr Amy Jennison9, Dr Rikki Graham9, Mr Haakon Bergh8, Dr Heather Wilson6, Dr Petra Derrington7 1Menzies Health Institute Queensland,...
  • July 31, 2017
Read More
Recent Comments
    Categories